Enhancing the ROS Sensitivity of a Responsive Supramolecular Hydrogel Using Peroxizyme Catalysis

Journal Article (2023)
Author(s)

I. Piergentili (TU Delft - ChemE/Advanced Soft Matter)

Thomas Hilberath (TU Delft - BT/Biocatalysis)

Benjamin Klemm (TU Delft - ChemE/Advanced Soft Matter)

F Hollmann (TU Delft - BT/Biocatalysis)

R Eelkema (TU Delft - ChemE/Advanced Soft Matter)

Research Group
ChemE/Advanced Soft Matter
Copyright
© 2023 I. Piergentili, T. Hilberath, B. Klemm, F. Hollmann, R. Eelkema
DOI related publication
https://doi.org/10.1021/acs.biomac.3c00262
More Info
expand_more
Publication Year
2023
Language
English
Copyright
© 2023 I. Piergentili, T. Hilberath, B. Klemm, F. Hollmann, R. Eelkema
Research Group
ChemE/Advanced Soft Matter
Issue number
7
Volume number
24
Pages (from-to)
3184-3192
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Hydrogels that can disintegrate upon exposure to reactive oxygen species (ROS) have the potential for targeted drug delivery to tumor cells. In this study, we developed a diphenylalanine (FF) derivative with a thioether phenyl moiety attached to the N-terminus that can form supramolecular hydrogels at neutral and mildly acidic pH. The thioether can be oxidized by ROS to the corresponding sulfoxide, which makes the gelator hydrolytically labile. The resulting oxidation and hydrolysis products alter the polarity of the gelator, leading to disassembly of the gel fibers. To enhance ROS sensitivity, we incorporated peroxizymes in the gels, namely, chloroperoxidase CiVCPO and the unspecific peroxygenase rAaeUPO. Both enzymes accelerated the oxidation process, enabling the hydrogels to collapse with 10 times lower H2O2 concentrations than those required for enzyme-free hydrogel collapse. These ROS-responsive hydrogels could pave the way toward optimized platforms for targeted drug delivery in the tumor microenvironment.